At the MRC Clinical Trials Unit,
systematic reviews and meta-analyses are a core part of our
work. We are committed to a rigorous, evidence-based approach
to planning trials.
This planning includes the need to decide
whether a systematic review or new trial offers the best means of
addressing specific questions.
The Meta-analysis Group research programme includes systematic
reviews and meta-analysis based on both individual patient data
(IPD) and summary data, as well as associated methodological
research.
The Meta-analysis Group also provides the main link between the
MRC Clinical Trials Unit and the Cochrane Collaboration.
Most of the Group’s work to date has been in the cancer field,
but our remit has extended to other diseases and conditions with
projects in Prion disease, pregnancy and wound care.
Future work will focus on key questions in cancer and in a range
of healthcare fields.
